Zhejiang "Dual Channels" catalog is announced, the provision of top three hospitals requires more than 30% (with national conditions)

Zhejiang has clarified that all 221 national talks are included in the "dual channel" of medical insurance

Today (November 26), Zhejiang Province released the list of drugs included in the "dual channel" management, and all 221 nationally negotiated varieties were included

At present, some provinces have begun to formulate implementation opinions of the "dual channel" management mechanism, and announced the inclusion of drugs

Guangdong, Hebei, Zhejiang: 221 drugs included

Anhui: 188 national talks included drugs

Hunan: 48 drugs included

Jiangxi: 53 drugs included

It can be seen that not all national talks drugs can enter the "dual-channel" management catalog of each province

Previously, on November 2, Zhejiang Provincial Medical Insurance Bureau and Zhejiang Provincial Health Commission jointly issued the "Notice of Zhejiang Provincial Medical Security Bureau and Zhejiang Provincial Health Commission on Implementing the "Dual Channel" Management Mechanism for Drugs in National Medical Insurance Negotiations", which was the first to propose National talks about variety allocation rate

In principle, it is required that the national drug product allocation rate should not be less than 30% for Grade 3 A public comprehensive medical institutions, Grade 3 B public comprehensive medical institutions, and Grade 3 public Chinese medicine hospitals (including integrated Chinese and Western medicine hospitals) should not be less than 20.

Before the end of November 2021, in principle, ensure that there is at least one "dual-channel" pharmacy in the county (city, district) area, and the municipal district can increase the number appropriately